AMERICAN CENTURY COMPANIES INC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 748054
KANSAS CITY, MO
Position in VNDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$970,638
-$60,741 QoQ
Shares Held
158,601
+6.3% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 172 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. VNDA ranks #89 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in VNDA
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $970,638 | 158,601 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,031,379 | 149,259 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,326,695 | 150,419 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $729,857 | 146,264 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $660,224 | 139,878 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,279,650 | 278,791 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,438,322 | 300,276 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,379,783 | 294,197 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,525,336 | 269,971 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $1,032,588 | 251,238 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $981,128 | 232,495 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $937,206 | 216,946 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $539,879 | 81,924 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $132,174 | 19,466 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $337,819 | 45,713 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $382,484 | 38,713 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $624,820 | 55,245 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $864,581 | 55,104 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $944,482 | 55,104 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 ALXN | — | 24,821 | Shares | Defined | 2021-08-05 | |
| 2021-06-30 | $1,168,917 | 54,343 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 ALXN | — | 25,644 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $816,231 | 54,343 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 ALXN | — | 104,782 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $693,502 | 52,778 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 ALXN | — | 241,375 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $804,214 | 83,252 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 ALXN | — | 26,992 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $823,119 | 71,951 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 ALXN | — | 4,633 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $1,017,994 | 98,262 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||